Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19710504 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Condition: Acute Myeloid Leukemia
Interventions: Drug: Phase I- Cytarabine & Eltrombopag;   Drug: Phase II- Sequence A;   Drug: Phase II- Sequence B

Indicates status has not been verified in more than two years